Infographic: how FTIR delivers the structural clarity and workflow efficiency needed to support the global scale-up of GLP-1 therapies.

This free resource from Specac explores how FTIR spectroscopy helps stabilise GLP-1 protein therapies by providing rapid, label-free insights into structural integrity across both solid and liquid formulations. It enables R&D and QC teams to detect aggregation and misfolding early, streamline workflows, and generate audit-ready data to meet global standards.

Here’s what’s included:

• Why structural consistency is a critical quality challenge as demand for GLP-1 drugs accelerates worldwide.
• How FTIR reveals peptide aggregation, pH-triggered misfolding, and metal-ion instability long before other tools.
• Practical gains for biopharma teams: confirm secondary structure in minutes, work across multiple formulations, and integrate inline with GMP and PAT frameworks.
• How Specac’s ConcentratIR2™ extends FTIR sensitivity to µg/mL concentrations, enabling reliable analysis of final formulations.